Stay updated on Nivolumab Ipilimumab Local Consolidation Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Local Consolidation Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Local Consolidation Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov page now presents the LONESTAR phase III trial record for nivolumab and ipilimumab with or without local consolidation therapy in patients with stage IV non-small cell lung cancer, replacing the error page.SummaryDifference69%

- Check14 days agoChange DetectedThe displayed site revision changes from v3.7.2 to v3.8.0, while the study page remains unavailable.SummaryDifference0.3%

- Check21 days agoChange DetectedA sitewide NIH announcement banner describes a transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe site revision label in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating access is blocked or unavailable. The site header and footer remain, but the main trial information cannot be viewed.SummaryDifference0.5%

Stay in the know with updates to Nivolumab Ipilimumab Local Consolidation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Local Consolidation Clinical Trial page.